Status of most problematic pressure injury [OASIS]   46542-7

LOINC Code


LOINC code46542-7
nameStatus of most problematic pressure injury [OASIS]
descriptionIdentifies the degree of healing visible in the ulcer identified as the most problematic observable pressure ulcer.
statusACTIVE

Fully-Specified Name

componentStatus of most problematic pressure injury
propertyFind  =  Finding
timePt  =  Point in time:  To identify measures at a point in time. This is a synonym for “spot” or “random” as applied to urine measurements.
system^Patient
scaleOrd  =  Ordinal:  Ordered categorical responses, e.g., 1+, 2+, 3+; positive, negative; reactive, indeterminate, nonreactive.
methodOASIS

Additional Names

short name

Basic Attributes

classSURVEY.OASIS
type4  Surveys

Associated Observations

LOINC codes that represent optional associated observation(s) for a clinical observation or laboratory test. A LOINC term may represent a single associated observation or panel containing several associated observations.

Member of these Panels

46462-8Deprecated Outcome and assessment information set (OASIS) form - version B1

History/Usage

first released
last updated2.64
last change typeNAM  - change to Analyte/Component
change reason"Pressure ulcer" has been updated to "pressure injury" according to the new guidelines by the NPUAP and as approved by the Clinical LOINC.

Related Names

Finding
Findings
Ordinal
Outcome and assessment information set
Point in time
pressure injury
Pressure ulcer
Pressure Ulcers
QL
Qual
Qualitative
Random
Screen
Survey
Survey.OASIS
Ulcer

Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © 1995-2024, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://loinc.org/license for the full LOINC copyright and license.

demo
request yours today
subscribe
start today
newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.